Company / SG&A per Share
Immunovant, Inc. SG&A per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.51
FY2024
5-year range
$0.39 / $0.51
FY2020-FY2024
Trend
+22.9%
vs FY2023
Sector context
#161 of 208
Health Care
What the data says
Immunovant, Inc.'s sg&a per share of $0.51 is lower than 77% of companies in the Health Care sector (FY2024). Increased from $0.39 to $0.51 over the past 2 years.
Based on SEC 10-K filings.
0.51 in FY2024 with a 5-year CAGR of +3.9%.
Increased from $0.39 to $0.51 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +3.9%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 208This company $0.51 Sector average $29.78
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 22.9% year-over-year.
- Ranks #161 out of 208 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.51 | +22.9% |
| FY2023 | $0.41 | +6.3% |
| FY2022 | $0.39 | -21.1% |
| FY2021 | $0.49 | +9.8% |
| FY2020 | $0.45 | +7.2% |
| FY2019 | $0.42 | +246.0% |
| FY2018 | $0.12 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026